Could shockwaves replace pills for overactive bladder?
NCT ID NCT07473310
First seen Mar 22, 2026 · Last updated Jun 19, 2026 · Updated 10 times
Summary
This study compares a new shockwave treatment to a standard daily pill for women with overactive bladder. Seventy women will receive either weekly shockwave sessions for 8 weeks or a daily medication for 12 months. Researchers will track symptom changes and quality of life over a year to see which approach works better and lasts longer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERACTIVE BLADDER (OAB) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mansoura Faculty of medicine
RECRUITINGAl Mansurah, Dakahlia Governorate, 35111, Egypt
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
low-intensity shockwave therapy (Li-SWT)
What this could lead to
If it works, this could offer a non-drug, non-invasive option for women with overactive bladder, reducing urgency and frequency without daily pills.
What could go wrong
This is a small Phase 4 trial with only 70 participants, so results may not apply to everyone. Shockwave therapy is still experimental for this condition, and its long-term benefits are uncertain.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.